FDA to weigh lifting restrictions on some MAHA-favored peptides

The Food and Drug Administration (FDA) is taking the first steps toward potentially easing access to certain peptide ...

Prediction: This 1 Thing Could Cement Eli Lilly's Leadership in the Billion-Dollar Weight Loss Drug Market

Eli Lilly (LLY 1.85%) has accomplished something big over the past year. It's become the leading weight loss drug company in ...

What happens when you go on Ozempic but you’re already thin?

A quick glance at any red carpet during awards season told the same story over and over: famous people, particularly A-list ...

GLP-1 Experimentation Is Everywhere, and Science Can’t Keep Up

He suggested that she ask her doctor about trying a GLP-1 drug off-label, a common practice in which a medication is ...

MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)

Company entered into an asset purchase agreement with Johnson & Johnson (J&J) to acquire all interests in botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP ...

Lexaria Bioscience Corp.: Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Contracts signed for Animal Study GLP-1-A26-1 KELOWNA, BC / ACCESS Newswire / April 15, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innovator in drug delivery ...